Shinichi Muramatsu

Direttore/Membro del Consiglio presso NIPPON PIGMENT COMPANY LIMITED

68 anni

Producer Manufacturing

Process Industries

Health Technology

Posizioni attive di Shinichi Muramatsu

Società	Posizione	Inizio	Fine
NIPPON PIGMENT COMPANY LIMITED	Direttore/Membro del Consiglio	28/06/2018	-
NIPPON PIGMENT COMPANY LIMITED	Independent Dir/Board Member	28/06/2018	-

Società	Posizione	Inizio	Fine
Gene Therapy Research Institution Co., Ltd. Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan.	Direttore/Membro del Consiglio	-	-
ICHIKAWA CO., LTD.	Direttore/Membro del Consiglio	01/07/2007	-
	Public Communications Contact	16/07/2010	27/07/2011
	Corporate Officer/Principal	19/01/2010	-
	Vendite & Marketing	27/07/2011	03/07/2015

Distribuzione geografica

Giappone

Posizioni

Director/Board Member	3
Public Communications Contact	1
Corporate Officer/Principal	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
ICHIKAWA CO., LTD.	Producer Manufacturing
NIPPON PIGMENT COMPANY LIMITED	Process Industries

Aziende private	1
Gene Therapy Research Institution Co., Ltd. Gene Therapy Research Institution Co., Ltd. BiotechnologyHealth Technology Gene Therapy Research Institution Co., Ltd. provides gene therapies for refractory diseases. It focuses on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company was founded on May 16, 2014 and is headquartered in Kawasaki, Japan.	Health Technology